By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Celladon Corporation 

c/o Enterprise Partners Venture Capital
2223 Avenida de la Playa, Suite 300
La Jolla  California  92037  U.S.A.
Phone: 858-731-0241 Fax:



Company News
Celladon Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 1/9/2015 7:47:40 AM
Celladon Corporation Conducts Initial Scale Up Of Manufacturing Process For MYDICAR To Commercial Scale 1/5/2015 7:21:03 AM
Celladon Corporation Added To NASDAQ Biotechnology Index 12/16/2014 8:02:23 AM
Celladon Corporation To Present At 11th Global Cardio Vascular Clinical Trial Forum 12/5/2014 10:28:22 AM
Celladon Corporation Selected To Present During The "Best Of Circulation Research" Symposium At The American Heart Association Scientific Sessions 2014 11/14/2014 10:25:22 AM
Celladon Corporation Reports Third Quarter 2014 Financial Results And Recent Highlights 11/12/2014 7:59:38 AM
Celladon Corporation To Present At Credit Suisse Healthcare Conference 11/10/2014 9:53:56 AM
Celladon Corporation To Present At Credit Suisse Healthcare Investor Conference 11/6/2014 10:14:55 AM
Lonza Group Ltd. (LZAGY.PK) And Celladon Corporation Establish A Strategic Commercial Manufacturing Collaboration For MYDICAR® 11/3/2014 7:47:56 AM
Celladon Corporation Announces Publication Of Data From Its Stem Cell Factor Gene Therapy Program In Circulation Heart Failure 10/27/2014 8:16:25 AM